GlassScriptPhysician profile
Alberto A Sabates
NPI 1902293475
$17,323.26
in general payments reported to CMS, 2019-2025
46 companies · $1,168 in 2025
The $1,168 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,522 · 2020: $1,911 · 2021: $2,096 · 2022: $2,369 · 2023: $3,566 · 2024: $3,692 · 2025: $1,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,884 · Grant: $272 · Travel and Lodging: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,884.36 |
| Grant | $271.74 |
| Travel and Lodging | $270.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,650.22 | 2019-2025 | Gallant, Cardiomems, Aveir |
| Boston Scientific Corporation | $1,513.71 | 2022-2025 | Watchman Flx, Watchman Access System, Watchman |
| Medtronic, INC. | $1,493.93 | 2021-2025 | Symplicity G3, Cobalt Dr Mri Surescan, Resolute Onyx |
| Inari Medical, INC. | $1,487.64 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $743.35 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $605.18 | 2022-2023 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $480.42 | 2019-2025 | Jardiance |
| Edwards Lifesciences Corporation | $445.30 | 2019-2024 | |
| Cardiovascular Systems INC. | $365.21 | 2019-2023 | Diamondback Coronary |
| Heartflow, INC. | $363.31 | 2023-2025 | Ffrct |
| Cvrx, INC. | $331.53 | 2023-2025 | Barostim Neo System |
| Philips North America LLC | $317.18 | 2024-2025 | (Cm9) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und |
| Astellas Pharma US INC | $313.99 | 2019-2021 | |
| Terumo Medical Corporation | $264.00 | 2023-2025 | Metacross Otw, Glidewire, Angio-Seal |
| E.R. Squibb & Sons, L.L.C. | $231.30 | 2023-2025 | Camzyos, Eliquis |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Sabates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.